GPR17
MOLECULAR TARGETG protein-coupled receptor 17
GPR17 (G protein-coupled receptor 17) is targeted by 8 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting GPR17
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
| # | Compound | Confidence | Active Assays |
|---|---|---|---|
| 1 | pranlukast | 3.30 | 26 |
| 2 | Uridine Diphosphate Galactose | 1.39 | 3 |
| 3 | Uridine Diphosphate Glucose | 1.39 | 3 |
| 4 | Leukotriene C4 | 1.10 | 2 |
| 5 | Uridine Diphosphate | 1.10 | 2 |
| 6 | Adenosine Triphosphate | 0.69 | 1 |
| 7 | Aminolevulinic Acid | 0.69 | 1 |
| 8 | Leukotriene E4 | 0.69 | 1 |
About GPR17 as a Drug Target
GPR17 (G protein-coupled receptor 17) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 8 compounds with documented GPR17 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
GPR17 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.